Clinical Trial Update: Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Dehydroepiandrosterone (DHEA) for respiratory pulmonary hypertension in adults. The sponsor is University Hospital, Bordeaux, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Chronic Obstructive Pulmonary Disease, Hypertension, Pulmonary | Phase 3 | Status: UNKNOWN